Novel potent benzimidazole-based microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C4 synthase
- 1 February 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 231, 114167
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
- TÜBİTAK
This publication has 38 references indexed in Scilit:
- Pyrazol-3-propanoic acid derivatives as novel inhibitors of leukotriene biosynthesis in human neutrophilsEuropean Journal of Medicinal Chemistry, 2011
- The Catalytic Architecture of Leukotriene C4 Synthase with Two Arginine ResiduesJournal of Biological Chemistry, 2011
- Licofelone Suppresses Prostaglandin E2 Formation by Interference with the Inducible Microsomal Prostaglandin E2 Synthase-1The Journal of Pharmacology and Experimental Therapeutics, 2008
- Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthaseNature, 2007
- OPM: Orientations of Proteins in Membranes databaseBioinformatics, 2006
- Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886Bioorganic & Medicinal Chemistry Letters, 2005
- Bioinformatic and enzymatic characterization of the MAPEG superfamilyThe FEBS Journal, 2005
- Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database ScreeningJournal of Medicinal Chemistry, 2004
- Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking AccuracyJournal of Medicinal Chemistry, 2004
- Phosphorylation‐ and stimulus‐dependent inhibition of cellular 5‐lipoxygenase activity by nonredox‐type inhibitorsThe FASEB Journal, 2003